Gore sponsors EVEResT Lunch Symposium

NewsGuard 100/100 Score

W. L. Gore & Associates (Gore) is sponsoring the EVEResT (European Virtual Reality Endovascular Research Team) Lunch Symposium taking place on Friday, Nov. 19 from 12:00 to 1:00 p.m. at the VEITHsymposium in the Gramercy A room, second floor. The symposium will detail the evidence for simulation in medical training and in other fields. Companies will demonstrate how new simulation technologies are designed to enhance performance in endovascular procedures.

“Gore has a long and successful history of providing new technologies and tools to support vascular surgeons and radiologists.”

Rapid advances in technology, combined with a demand for increased patient safety, have led to a growing interest in simulation as a training tool to prepare physicians for complex procedures without harming the patient. As a result, some of the world's leading vascular surgeons and radiologists are participating in the event. EVEResT is chaired by Professor Nicholas Cheshire, MD, Professor of Vascular Surgery, Head of Circulation Sciences and Renal Medicine, Imperial College Healthcare, Campus St. Mary's Hospital, London; Professor Mario Lachat, MD, Head of Cardiovascular Surgery, University Hospital, Zurich, Switzerland; and Dr. Isabelle van Herzeele, MD, PhD, consultant at the Department of Thoracic and Vascular Surgery at Ghent University Hospital, Belgium and Honorary Fellow at the Department of Biosurgery and Surgical Technology NHS Trust, Campus St. Mary's Hospital, London.

"We are sponsoring this important event in order to help properly showcase the tremendous advances in simulation technology that are improving performance in endovascular procedures and patient outcomes," commented David Abeyta, Aortic Business Unit Leader at Gore. "Gore has a long and successful history of providing new technologies and tools to support vascular surgeons and radiologists."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings